Literature DB >> 7567227

Association of idiopathic hypopituitarism and syringomyelia.

T Aihara1, M Nishikawa, N Koda, T Abe.   

Abstract

The magnetic resonance in an 8-year-old boy with hypopituitarism and cervical syringomyelia are presented. Magnetic resonance imaging of the brain clearly demonstrated syringomyelia in the cervical spinal cord and transection of the pituitary stalk, findings identical to those reported in the literature. Both disorders have been seen in association with a difficult labor, so we suggest that this is not a chance finding.

Entities:  

Mesh:

Year:  1995        PMID: 7567227     DOI: 10.1007/BF02011089

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  4 in total

1.  Survey studies on pituitary diseases in Japan.

Authors:  K Shizume; Y Harada; H Ibayashi; Y Kumahara; N Shimizu
Journal:  Endocrinol Jpn       Date:  1977-04

2.  Transection of the pituitary stalk: development of an ectopic posterior lobe assessed with MR imaging.

Authors:  I Fujisawa; K Kikuchi; K Nishimura; K Togashi; K Itoh; S Noma; S Minami; T Sagoh; T Hiraoka; T Momoi
Journal:  Radiology       Date:  1987-11       Impact factor: 11.105

3.  Difficult labour as a cause of communicating syringomyelia.

Authors:  B Williams
Journal:  Lancet       Date:  1977-07-09       Impact factor: 79.321

4.  The association of hypopituitarism with small pituitary, invisible pituitary stalk, type 1 Arnold-Chiari malformation, and syringomyelia in seven patients born in breech position: a further proof of birth injury theory on the pathogenesis of "idiopathic hypopituitarism".

Authors:  K Fujita; N Matsuo; O Mori; N Koda; E Mukai; Y Okabe; N Shirakawa; S Tamai; Y Itagane; I Hibi
Journal:  Eur J Pediatr       Date:  1992-04       Impact factor: 3.183

  4 in total
  1 in total

1.  Resolution of syringomyelia and Chiari malformation after growth hormone therapy.

Authors:  Ashok Gupta; Aleksander M Vitali; Ralph Rothstein; D Douglas Cochrane
Journal:  Childs Nerv Syst       Date:  2008-07-12       Impact factor: 1.475

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.